Neuroimaging in Dementia

Neurologic Clinics

Volumn 25, Issue 3, 2007, Pages 843-857

  Whitwell, Jennifer L ^a   Jack Jr , Clifford R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; BEHAVIOR CHANGE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN REGION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE PREDISPOSITION; FAMILY HISTORY; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC SUSCEPTIBILITY; GLUCOSE TRANSPORT; GRAY MATTER; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

BRAIN; DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447310291     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2007.03.003     Document Type: Review

References (52)

1. Wahlund L.O., Julin P., Johansson S.E., et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69 5 (2000) 630-635
2. Jack Jr. C.R., Dickson D.W., Parisi J.E., et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58 5 (2002) 750-757
3. Whitwell J.L., and Jack Jr. C.R. Comparisons between Alzheimer's disease, frontotemporal lobar degeneration, and normal ageing with brain mapping. Top Magn Reson Imaging 16 (2006) 409-425
4. Frisoni G.B., Testa C., Sabattoli F., et al. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry 76 1 (2005) 112-114
5. Fox N.C., Warrington E.K., Freeborough P.A., et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 119 Pt 6 (1996) 2001-2007
6. Farlow M.R., He Y., Tekin S., et al. Impact of APOE in mild cognitive impairment. Neurology 63 10 (2004) 1898-1901
7. Jack Jr. C.R., Petersen R.C., Xu Y.C., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52 7 (1999) 1397-1403
8. Likeman M., Anderson V.M., Stevens J.M., et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol 62 9 (2005) 1410-1415
9. Rosen H.J., Gorno-Tempini M.L., Goldman W.P., et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58 2 (2002) 198-208
10. Josephs K.A., Duffy J.R., Strand E.A., et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129 (2006) 1385-1398
11. Chan D., Fox N.C., Scahill R.I., et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 49 4 (2001) 433-442
12. Whitwell J.L., Weigand S.D., Shiung M.M., et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 130 (2007) 708-719
13. Varma A.R., Laitt R., Lloyd J.J., et al. Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias. Acta Neurol Scand 105 5 (2002) 355-364
14. Varma A.R., Adams W., Lloyd J.J., et al. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 105 4 (2002) 261-269
15. Whitwell J.L., Jack C.R., et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 130 (2007) 1148-1158
16. Barnes J., Scahill R.I., Boyes R.G., et al. Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. Neuroimage 23 2 (2004) 574-581
17. Jack Jr. C.R., Shiung M.M., Weigand S.D., et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65 8 (2005) 1227-1231
18. Fox N.C., Crum W.R., Scahill R.I., et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358 9277 (2001) 201-205
19. Thompson P.M., Hayashi K.M., de Zubicaray G., et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23 3 (2003) 994-1005
20. Mosconi L., De Santi S., Li Y., et al. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur J Nucl Med Mol Imaging 33 2 (2006) 210-221
21. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32 4 (2005) 486-510
22. Jagust W., Gitcho A., Sun F., et al. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol 59 4 (2006) 673-681
23. Ibach B., Poljansky S., Marienhagen J., et al. Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease. Neuroimage 23 2 (2004) 739-743
24. Jeong Y., Cho S.S., Park J.M., et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 46 2 (2005) 233-239
25. Bonte F.J., Harris T.S., Roney C.A., et al. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J Nucl Med 45 5 (2004) 771-774
26. Zahn R., Buechert M., Overmans J., et al. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography. Psychiatry Res 140 2 (2005) 115-131
27. McMurtray A.M., Chen A.K., Shapira J.S., et al. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 66 4 (2006) 517-522
28. Minoshima S., Foster N.L., Sima A.A., et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50 3 (2001) 358-365
29. Gilman S., Koeppe R.A., Little R., et al. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Exp Neurol 191 Suppl 1 (2005) S95-S103
30. Kerrouche N., Herholz K., Mielke R., et al. (18)FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis. J Cereb Blood Flow Metab 26 9 (2006) 1213-1221
31. Sperling R.A., Bates J.F., Chua E.F., et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 1 (2003) 44-50
32. Machulda M.M., Ward H.A., Borowski B., et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61 4 (2003) 500-506
33. Johnson S.C., Schmitz T.W., Moritz C.H., et al. Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiol Aging 27 11 (2005) 1604-1612
34. Bookheimer S.Y., Strojwas M.H., Cohen M.S., et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343 7 (2000) 450-456
35. Johnson S.C., Schmitz T.W., Trivedi M.A., et al. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci 26 22 (2006) 6069-6076
36. Buckner R.L., Snyder A.Z., Shannon B.J., et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25 34 (2005) 7709-7717
37. Rombouts S.A., Barkhof F., Goekoop R., et al. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp 26 4 (2005) 231-239
38. Kantarci K., Jack Jr. C.R., Xu Y.C., et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 55 2 (2000) 210-217
39. Modrego P.J., Fayed N., and Pina M.A. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 162 4 (2005) 667-675
40. Kantarci K., Weigand S.D., Petersen R.C., et al. Longitudinal (1)H MRS changes in mild cognitive impairment and Alzheimer's disease. [Epub] Neurobiol Aging 129 11 (2006) 2856-2866
41. Kantarci K., Petersen R.C., Boeve B.F., et al. 1H MR spectroscopy in common dementias. Neurology 63 8 (2004) 1393-1398
42. Mihara M., Hattori N., Abe K., et al. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex. Neuroreport 17 4 (2006) 413-416
43. Coulthard E., Firbank M., English P., et al. Proton magnetic resonance spectroscopy in frontotemporal dementia. J Neurol 253 7 (2006) 861-868
44. Kantarci K., Petersen R.C., Boeve B.F., et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64 5 (2005) 902-904
45. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 3 9 (2004) 519-527
46. Shoghi-Jadid K., Small G.W., Agdeppa E.D., et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10 1 (2002) 24-35
47. Klunk W.E., Engler H., Nordberg A., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55 3 (2004) 306-319
48. Newberg A.B., Wintering N.A., Plossl K., et al. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J Nucl Med 47 5 (2006) 748-754
49. Mintun M.A., Larossa G.N., Sheline Y.I., et al. [11C] PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67 3 (2006) 446-452
50. Engler H., Forsberg A., Almkvist O., et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain (Jul 19 2006)
51. Lopresti B.J., Klunk W.E., Mathis C.A., et al. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 46 12 (2005) 1959-1972
52. Rowe C.R., Ng S., Gong S.J., et al. C-11 PIB PET amyloid imaging in aging and dementia. Alzheimer's & Dementia 2 3 (2006) S66